HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Bernard Klein Selected Research
Bernard Klein Research Topics
Disease
53
Multiple Myeloma
03/2019 - 04/2002
27
Neoplasms (Cancer)
06/2017 - 08/2002
5
Chromosome Aberrations (Chromosome Abnormalities)
11/2015 - 04/2009
3
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2016 - 03/2009
3
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2011 - 02/2007
2
Testicular Neoplasms (Testicular Cancer)
04/2011 - 07/2009
2
Starvation
10/2007 - 05/2003
1
COVID-19
01/2021
1
Monoclonal Gammopathy of Undetermined Significance
01/2019
1
Lymphoma (Lymphomas)
01/2016
1
Hematologic Neoplasms (Hematological Malignancy)
01/2016
1
Carcinogenesis
01/2016
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1
Inflammation (Inflammations)
03/2015
1
Anemia
03/2015
1
Castleman Disease (Castleman's Disease)
03/2015
1
Rheumatoid Arthritis
03/2015
1
Bone Diseases (Bone Disease)
02/2015
1
Disease Progression
01/2014
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2013
1
Ewing Sarcoma (Sarcoma, Ewing)
12/2012
1
Prostatic Neoplasms (Prostate Cancer)
12/2012
1
Residual Neoplasm
11/2012
1
Paraproteinemias (Monoclonal Gammopathy)
07/2011
1
Myocardial Infarction
07/2011
1
Neoplasm Metastasis (Metastasis)
04/2010
1
Trisomy (Trisomies)
04/2010
1
Lymphopenia (Lymphocytopenia)
01/2010
Drug/Important Bio-Agent (IBA)
8
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2015 - 08/2003
6
Antigens
IBA
03/2013 - 04/2006
5
DNA (Deoxyribonucleic Acid)
IBA
11/2015 - 10/2002
5
Interleukin-6 (Interleukin 6)
IBA
03/2015 - 05/2003
4
Melphalan (Alkeran)
FDA Link
Generic
03/2019 - 01/2010
4
Pharmaceutical Preparations
IBA
03/2015 - 12/2007
3
Lenalidomide (CC 5013)
FDA Link
05/2016 - 07/2011
3
Biological Products
IBA
11/2015 - 01/2008
3
Cytokines
IBA
03/2013 - 01/2010
3
Proteins (Proteins, Gene)
FDA Link
12/2012 - 01/2011
3
Peptides (Polypeptides)
IBA
01/2010 - 04/2006
3
Syndecan-1 (Syndecan 1)
IBA
08/2009 - 06/2007
3
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
07/2009 - 04/2006
3
Proteoglycans (Proteoglycan)
IBA
05/2009 - 06/2007
3
Heparin (Liquaemin)
FDA Link
Generic
05/2009 - 05/2005
2
tocilizumab (atlizumab)
FDA Link
01/2021 - 03/2015
2
MicroRNAs (MicroRNA)
IBA
06/2017 - 11/2015
2
Thalidomide (Thalomid)
FDA Link
05/2016 - 03/2013
2
Interferons
IBA
03/2013 - 03/2011
2
Rituximab (Mabthera)
FDA Link
03/2011 - 06/2008
2
Monoclonal Antibodies
IBA
03/2011 - 10/2003
2
Interleukin-2 (IL2)
IBA
03/2011 - 10/2007
2
thymosin beta(4)
IBA
04/2010 - 01/2010
2
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
08/2009 - 03/2009
2
Messenger RNA (mRNA)
IBA
07/2009 - 12/2008
2
Neoplasm Antigens (Tumor Antigens)
IBA
07/2009 - 08/2002
2
HLA Antigens (Human Leukocyte Antigens)
IBA
07/2009 - 04/2006
2
Heparitin Sulfate (Heparan Sulfate)
IBA
03/2009 - 06/2007
2
ErbB Receptors (EGF Receptor)
IBA
03/2004 - 04/2002
1
Antioxidants
IBA
03/2019
1
Bromodeoxyuridine (BrdU)
IBA
01/2019
1
pomalidomide
IBA
05/2016
1
chetomin
IBA
03/2016
1
RecQ Helicases
IBA
01/2016
1
Acute-Phase Proteins (Acute-Phase Protein)
IBA
03/2015
1
Interleukin-6 Inhibitors
IBA
03/2015
1
siltuximab
IBA
03/2015
1
Methyltransferases
IBA
02/2015
1
Histone Deacetylase Inhibitors
IBA
02/2015
1
Insulin-Like Growth Factor Binding Proteins
IBA
02/2015
1
Bone Morphogenetic Proteins (Bone Morphogenetic Protein)
IBA
02/2015
1
Survivin
IBA
11/2014
1
sepantronium
IBA
11/2014
1
A-Form DNA (A-DNA)
IBA
05/2014
1
Alkylating Agents
IBA
09/2013
1
Immunoglobulins (Immunoglobulin)
IBA
09/2013
1
Nucleotides
IBA
06/2013
1
Carcinoembryonic Antigen
IBA
05/2013
1
Cell Adhesion Molecules
IBA
05/2013
1
Enzymes
IBA
01/2013
1
Polysaccharides (Glycans)
IBA
01/2013
1
Proteasome Inhibitors
IBA
11/2012
1
Dexamethasone (Maxidex)
FDA Link
Generic
11/2012
1
Annexin A2 (Annexin II)
IBA
08/2012
1
Bortezomib (Velcade)
FDA Link
03/2012
1
Growth Differentiation Factor 15
IBA
03/2012
1
Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)
IBA
05/2011
1
Sulfatases
IBA
05/2011
1
ofatumumab
FDA Link
03/2011
1
Perforin
IBA
03/2011
1
Granzymes (Granzyme)
IBA
03/2011
1
Complement System Proteins (Complement)
IBA
03/2011
1
bromohydrin pyrophosphate
IBA
03/2011
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
04/2010
1
Thymosin
IBA
01/2010
1
Indicators and Reagents (Reagents)
IBA
08/2009
Therapy/Procedure
11
Therapeutics
03/2015 - 10/2003
9
Immunotherapy
05/2013 - 04/2006
4
Drug Therapy (Chemotherapy)
11/2015 - 01/2010
2
Stem Cell Transplantation
03/2013 - 01/2010
1
Immunomodulation
02/2015
1
Transplantation
11/2012